Skip to content

Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype

Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02387177
Enrollment
51
Registered
2015-03-12
Start date
2015-01-31
Completion date
2017-12-31
Last updated
2018-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurofibromatoses

Brief summary

The aim of this research is to adapt the NF-specific adult version of the Skype 3RP for use with adolescents, and to test its feasibility, acceptability, and preliminary effect in improving quality of life, and in decreasing stress and psychological distress.

Interventions

Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.

Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.

Sponsors

The Children's Tumor Foundation
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

1. Must be between the ages of 12 and 17 2. Can read and speak English at or above the 6th grade level 3. Diagnosis of neurofibromatosis type 1 or neurofibromatosis type 2 by a specialized medical provider

Exclusion criteria

1. Severe active or untreated major mental illness that would interfere with study participation, to be determined at the discretion of the study investigator (e.g. untreated psychosis or suicidality) 2. Recent (within past 3 months) change in antidepressant medication 3. Use of formal relaxation training (including past participation in a mind-body program), currently or in the past 6 months 4. Unable or unwilling to sign the informed consent documents 5. Unable or unwilling to participate in an intervention delivered via videoconferencing with Skype

Design outcomes

Primary

MeasureTime frameDescription
Quality of life (WHO-QOLBREFadol)Change between Baseline (week0), Post-intervention (Week8) and Follow Up (Week 36)Measures quality of life

Secondary

MeasureTime frameDescription
Epworth Sleepiness Scale-Revised for Children (ESS)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Measures how likely one is to doze off or sleep in certain situations
Measure of Current Status (MOCS) Part AChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Measures participants' current self-perceived status on several skills that are targeted by the intervention: the ability to relax at will, recognize stress-inducing situations, restructure maladaptive thoughts, be assertive about needs, and choose appropriate coping responses as needed.
Generalized Anxiety Disorder 7-item (GAD-7) scaleChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)A brief measure for assessing generalized anxiety disorder
Quality of Life (WHOQOL-BREF)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)The WHOQOL-BREF comprises of 26 items which measure the following broad domains: physical health, psychological health, social relationships, and environment. The WHOQOL-BREF is a shorter version of the original instrument that may be more convenient for use in large research studies or clinical trials.
Satisfaction with life adolescentChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)measures global satisfaction with life
Perceived Stress Scale (PSS-10)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Situations in one's life over the past month/week are appraised as stressful
The Pain Catastrophizing Scale - Child Version (PCS-C)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Measures how individuals experience pain
Patient Health Questionnaire for Adolescents (PHQ-A)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Symptoms of depression and functional impairment
Pain Interference Index (PII)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)How much pain has interfered with their life
Child and Adolescent Mindfulness Measure (CAMM)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Assesses mindfulness in children and adolescents
Interpersonal Reactivity Index (IRI)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Assesses the cognitive and affective dimensions of empathy
Gratitude Questionnaire Six-Item Form (GQ-6)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Assesses individual differences in the proneness to experience gratitude in daily life
Life Orientation Test (LOT) Optimism ScaleChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Individual differences in generalized optimism versus pessimism
Functional Assessment of Chronic Illness Therapy- Spiritual Well-Being Scale (FACIT-Sp)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Spiritual well-being (sense of meaning in life and the sense of strength in one's faith) over the past 7 days
MOS (Support/Empathy)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)Measures recent thinking about the various dimensions of social support.

Other

MeasureTime frameDescription
Intent to AttendBaseline (week 0)Measures how likely and how motivated the participants is to attend the next session.
Participant Feedback - Program Satisfaction QuestionnairePost-intervention (week 8)Measures how satisfied the participant is with the intervention
DemographicsBaseline (week 0)Basic demographics
Expectancy QuestionnaireBaseline (week 0)Measures how much the participant believes the intervention will work

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026